Effect of mixodin supplementation on inflammatory and oxidative stress markers, clinical symptoms, mental health, and quality of life in patients with migraine: study protocol for a randomized clinical trial
The protocol is Version 2.0, March 01, 2025. Recruitment began November 11, 2024, and is anticipated to be completed by June 22, 2025.
Authors
- Mohammadreza Askari (ORCID: https://orcid.org/0000-0002-7582-7833)
- Mahdi Vajdi (ORCID: https://orcid.org/0000-0002-2828-1161)
- Fariborz Khorvash
- Afsaneh Yegdaneh
Institutions
- Isfahan University of Medical Sciences (IR)
Publication Details
- Journal
- Trials
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1186/s13063-025-09166-1
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00